BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kageyama K, Bradbury MJ, Zhao L, Blount AL, Vale WW. Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. Endocrinology 1999;140:5651-8. [PMID: 10579329 DOI: 10.1210/endo.140.12.7223] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Binder EB, Nemeroff CB. The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry. 2010;15:574-588. [PMID: 20010888 DOI: 10.1038/mp.2009.141] [Cited by in Crossref: 224] [Cited by in F6Publishing: 214] [Article Influence: 17.2] [Reference Citation Analysis]
2 Kageyama K, Suda T. Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5'-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells. Endocrinology 2003;144:2234-41. [PMID: 12746280 DOI: 10.1210/en.2002-0023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lu W, Dow L, Gumusgoz S, Brierley MJ, Warne JM, McCrohan CR, Balment RJ, Riccardi D. Coexpression of corticotropin-releasing hormone and urotensin i precursor genes in the caudal neurosecretory system of the euryhaline flounder (Platichthys flesus): a possible shared role in peripheral regulation. Endocrinology 2004;145:5786-97. [PMID: 15358672 DOI: 10.1210/en.2004-0144] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 3.2] [Reference Citation Analysis]
4 Borges LE, Bloise E, Dela Cruz C, Galleri L, Apa R, Petraglia F, Reis FM. Urocortin 1 expression and secretion by human umbilical vein endothelial cells: In vitro effects of interleukin 8, interferon γ, lipopolysaccharide, endothelin 1, prostaglandin F-2α, estradiol, progesterone and dexamethasone. Peptides 2015;74:64-9. [PMID: 26549126 DOI: 10.1016/j.peptides.2015.10.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
5 Chatzaki E, Kefala N, Drosos I, Lalidou F, Baritaki S. Do urocortins have a role in treating cardiovascular disease? Drug Discovery Today 2019;24:279-84. [DOI: 10.1016/j.drudis.2018.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Polat H, Mamuk S, Akarsu ES. Hormonal synchronization of lipopolysaccharide-induced hypothermic response in rats. J Endocrinol Invest 2013;36:816-24. [PMID: 23612418 DOI: 10.3275/8945] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Tillinger A, Padová A, Mravec B, Tomova A. Stressors affect urocortin 1 and urocortin 2 gene expression in rat spleen: The role of glucocorticoids. J Neuroimmunol 2019;336:577030. [PMID: 31473519 DOI: 10.1016/j.jneuroim.2019.577030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Tsatsanis C, Androulidaki A, Dermitzaki E, Charalampopoulos I, Spiess J, Gravanis A, Margioris AN. Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR 2. FEBS Letters 2005;579:4259-64. [DOI: 10.1016/j.febslet.2005.06.057] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis]
9 Arase S, Watanabe Y, Setoyama H, Nagaoka N, Kawai M, Matsumoto S. Disturbance in the Mucosa-Associated Commensal Bacteria Is Associated with the Exacerbation of Chronic Colitis by Repeated Psychological Stress; Is That the New Target of Probiotics? PLoS One 2016;11:e0160736. [PMID: 27500935 DOI: 10.1371/journal.pone.0160736] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
10 Kageyama K, Gaudriault GE, Bradbury MJ, Vale WW. Regulation of Corticotropin-Releasing Factor Receptor Type 2β Messenger Ribonucleic Acid in the Rat Cardiovascular System by Urocortin, Glucocorticoids, and Cytokines*. Endocrinology 2000;141:2285-93. [DOI: 10.1210/endo.141.7.7572] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 1.4] [Reference Citation Analysis]
11 Waters RP, Rivalan M, Bangasser DA, Deussing JM, Ising M, Wood SK, Holsboer F, Summers CH. Evidence for the role of corticotropin-releasing factor in major depressive disorder. Neurosci Biobehav Rev 2015;58:63-78. [PMID: 26271720 DOI: 10.1016/j.neubiorev.2015.07.011] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 7.9] [Reference Citation Analysis]
12 Popov SV, Prokudina ES, Mukhomedzyanov AV, Naryzhnaya NV, Ma H, Zurmanova JM, der Ven PFMV, Maslov LN. Cardioprotective and Vasoprotective Effects of Corticotropin-Releasing Hormone and Urocortins: Receptors and Signaling. J Cardiovasc Pharmacol Ther 2021;:1074248420985301. [PMID: 34351805 DOI: 10.1177/1074248420985301] [Reference Citation Analysis]
13 Paschos KA, Charsou C, Constantinidis TC, Anagnostoulis S, Lambropoulou M, Papachristou F, Simopoulos K, Chatzaki E. Corticotropin-releasing hormone receptors mediate opposing effects in cholestasis-induced liver cell apoptosis. Endocrinology. 2010;151:1704-1712. [PMID: 20189999 DOI: 10.1210/en.2009-1208] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
14 Stevens SL, Shaw TE, Dykhuizen E, Lessov NS, Hill JK, Wurst W, Stenzel-Poore MP. Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: a potential link to microglia and atrocytes that express CRH-R1. J Cereb Blood Flow Metab 2003;23:1151-9. [PMID: 14526225 DOI: 10.1097/01.WCB.0000086957.72078.D4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
15 Yuan PQ, Wu SV, Pothoulakis C, Taché Y. Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect. Am J Physiol Gastrointest Liver Physiol 2016;310:G387-98. [PMID: 26744472 DOI: 10.1152/ajpgi.00337.2015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
16 Wu Y, Zhou H, Xu Y, Li S. Enhanced expression of urocortin in lung tissues of rats with allergic asthma. Biochemical and Biophysical Research Communications 2006;341:532-40. [DOI: 10.1016/j.bbrc.2005.12.214] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Qi J, Zhang X, Li Y, Xu S, Wang M, Chen H, Tang N, Wang S, Wang B, Chen D, Zhou B, Li Z. The suppression effects of feeding and mechanisms in CRF system of animals. Gene 2020;733:144363. [PMID: 31935510 DOI: 10.1016/j.gene.2020.144363] [Reference Citation Analysis]
18 Chae JI, Ju SK, Lee MK, Park JH, Yoon JH, Shim JH, Lee DS. cDNA cloning and analysis of tissue-specific gene expression of rat urocortin II. Mol Biol 2009;43:82-7. [DOI: 10.1134/s0026893309010117] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
19 Gonzalez-Rey E, Chorny A, Varela N, Robledo G, Delgado M. Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response. Am J Pathol. 2006;168:1921-1930. [PMID: 16723707 DOI: 10.2353/ajpath.2006.051104] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 3.7] [Reference Citation Analysis]
20 Heinrichs SC, Tache Y. Therapeutic potential of CRF receptor antagonists: a gut-brain perspective. Expert Opin Investig Drugs. 2001;10:647-659. [PMID: 11281815 DOI: 10.1517/13543784.10.4.647] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
21 Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M. Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn’s disease. Gut. 2006;55:824-832. [PMID: 16401687 DOI: 10.1136/gut.2005.084525] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 4.7] [Reference Citation Analysis]
22 Chang J, Adams MR, Clifton MS, Liao M, Brooks JH, Hasdemir B, Bhargava A. Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2. Am J Physiol Gastrointest Liver Physiol. 2011;300:G884-G894. [PMID: 21330446 DOI: 10.1152/ajpgi.00319.2010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
23 Kageyama K, Sakihara S, Yamashita M, Takahashi K, Kawashima S, Tanabe J, Tsutaya S, Yasujima M, Suda T. A case of multiple endocrine neoplasia type II accompanied by thyroid medullary carcinoma and pheochromocytomas expressing corticotropin-releasing factor and urocortins. Am J Med Sci 2008;335:398-402. [PMID: 18480660 DOI: 10.1097/MAJ.0b013e31815200f8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
24 la Fleur SE, Wick EC, Idumalla PS, Grady EF, Bhargava A. Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum. Proc Natl Acad Sci U S A 2005;102:7647-52. [PMID: 15883387 DOI: 10.1073/pnas.0408531102] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 4.7] [Reference Citation Analysis]
25 Arcuri F, Cintorino M, Florio P, Floccari F, Pergola L, Romagnoli R, Petraglia F, Tosi P, Teresa Del Vecchio M. Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma. Prostate 2002;52:167-72. [PMID: 12111693 DOI: 10.1002/pros.10094] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
26 Maillot C, Million M, Wei JY, Gauthier A, Taché Y. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats. Gastroenterology. 2000;119:1569-1579. [PMID: 11113078 DOI: 10.1053/gast.2000.20251] [Cited by in Crossref: 150] [Cited by in F6Publishing: 149] [Article Influence: 7.1] [Reference Citation Analysis]
27 Neufeld-Cohen A, Evans AK, Getselter D, Spyroglou A, Hill A, Gil S, Tsoory M, Beuschlein F, Lowry CA, Vale W, Chen A. Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits. Mol Psychiatry 2010;15:426-41, 339. [PMID: 19884890 DOI: 10.1038/mp.2009.115] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
28 Berczi I. Neuroendocrine Regulation of Natural Immunity. Natural Immunity. Elsevier; 2005. pp. 215-62. [DOI: 10.1016/s1567-7443(05)80017-1] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
29 Tezval H, Dubrowinskaja N, Peters I, Reese C, Serth K, Atschekzei F, Hennenlotter J, Stenzl A, Kuczyk MA, Serth J. Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis. PLoS One 2016;11:e0163873. [PMID: 27695045 DOI: 10.1371/journal.pone.0163873] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
30 Lee S, Braden B, Kang SS, Rivier C. Urocortins are present in the rat testis. Neuropeptides 2011;45:131-7. [PMID: 21256589 DOI: 10.1016/j.npep.2010.12.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
31 Scarabelli TM, Pasini E, Stephanou A, Comini L, Curello S, Raddino R, Ferrari R, Knight R, Latchman DS. Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion. J Am Coll Cardiol 2002;40:155-61. [PMID: 12103270 DOI: 10.1016/s0735-1097(02)01930-7] [Cited by in Crossref: 59] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
32 Yuan PQ, Wu SV, Wang L, Taché Y. Corticotropin releasing factor in the rat colon: expression, localization and upregulation by endotoxin. Peptides. 2010;31:322-331. [PMID: 19944726 DOI: 10.1016/j.peptides.2009.11.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
33 Hasdemir B, Mhaske P, Paruthiyil S, Garnett EA, Heyman MB, Matloubian M, Bhargava A. Sex- and corticotropin-releasing factor receptor 2- dependent actions of urocortin 1 during inflammation. Am J Physiol Regul Integr Comp Physiol 2016;310:R1244-57. [PMID: 27053649 DOI: 10.1152/ajpregu.00445.2015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
34 Wu Y, Zhou H, Xu Y, Li S. Enhanced expression of urocortin in lung tissues of rats with allergic asthma. Biochem Biophys Res Commun 2006;341:532-40. [PMID: 16427607 DOI: 10.1016/j.bbrc.2005.12.214] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
35 Sinnayah P, Blair-west JR, Mcburnie MI, Mckinley MJ, Oldfield BJ, Rivier J, Vale WW, Walker LL, Weisinger RS, Denton DA. The effect of urocortin on ingestive behaviours and brain Fos immunoreactivity in mice. Eur J Neurosci 2003;18:373-82. [DOI: 10.1046/j.1460-9568.2003.02760.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
36 Kageyama K, Teui K, Tamasawa N, Suda T. Regulation and roles of urocortins in the vascular system. Int J Endocrinol 2012;2012:873723. [PMID: 22654906 DOI: 10.1155/2012/873723] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Kageyama K, Li C, Vale WW. Corticotropin-Releasing Factor Receptor Type 2 Messenger Ribonucleic Acid in Rat Pituitary: Localization and Regulation by Immune Challenge, Restraint Stress, and Glucocorticoids. Endocrinology 2003;144:1524-32. [DOI: 10.1210/en.2002-221046] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.6] [Reference Citation Analysis]
38 Kageyama K, Hasegawa G, Akimoto K, Yamagata S, Tamasawa N, Suda T. Differential regulation of gonadotropin-releasing hormone by corticotropin-releasing factor family peptides in hypothalamic N39 cells. Peptides 2012;33:149-55. [PMID: 22138165 DOI: 10.1016/j.peptides.2011.11.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
39 Kaprara A, Pazaitou-Panayiotou K, Kortsaris A, Chatzaki E. The corticotropin releasing factor system in cancer: expression and pathophysiological implications. Cell Mol Life Sci. 2010;67:1293-1306. [PMID: 20143250 DOI: 10.1007/s00018-010-0265-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
40 Kageyama K. Regulation of gonadotropins by corticotropin-releasing factor and urocortin. Front Endocrinol (Lausanne) 2013;4:12. [PMID: 23431022 DOI: 10.3389/fendo.2013.00012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
41 Kageyama K, Furukawa K, Miki I, Terui K, Motomura S, Suda T. Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta. J Cardiovasc Pharmacol 2003;42:561-5. [PMID: 14508243 DOI: 10.1097/00005344-200310000-00015] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 2.8] [Reference Citation Analysis]
42 Watanuki Y, Takayasu S, Kageyama K, Iwasaki Y, Sakihara S, Terui K, Nigawara T, Suda T. Involvement of Nurr-1/Nur77 in corticotropin-releasing factor/urocortin1-induced tyrosinase-related protein 1 gene transcription in human melanoma HMV-II cells. Molecular and Cellular Endocrinology 2013;370:42-51. [DOI: 10.1016/j.mce.2013.01.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
43 Sharma S, Kanwar K, Kanwar SS. Ascorbyl palmitate synthesis in an organic solvent system using a Celite-immobilized commercial lipase (Lipolase 100L). 3 Biotech 2016;6:183. [PMID: 28330255 DOI: 10.1007/s13205-016-0486-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
44 Watanuki Y, Kageyama K, Takayasu S, Matsuzaki Y, Iwasaki Y, Daimon M. Ultraviolet B radiation-stimulated urocortin 1 is involved in tyrosinase-related protein 1 production in human melanoma HMV-II cells. Peptides 2014;61:93-7. [PMID: 25240771 DOI: 10.1016/j.peptides.2014.09.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
45 Yuan PQ, Wu SV, Taché Y. Urocortins and CRF type 2 receptor isoforms expression in the rat stomach are regulated by endotoxin: role in the modulation of delayed gastric emptying. Am J Physiol Gastrointest Liver Physiol 2012;303:G20-31. [PMID: 22517775 DOI: 10.1152/ajpgi.00547.2011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
46 Pan W, Kastin AJ. Urocortin and the brain. Prog Neurobiol 2008;84:148-56. [PMID: 18078706 DOI: 10.1016/j.pneurobio.2007.10.008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 4.1] [Reference Citation Analysis]
47 Gonzalez-Rey E, Chorny A, Delgado M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol 2007;7:52-63. [PMID: 17186031 DOI: 10.1038/nri1984] [Cited by in Crossref: 151] [Cited by in F6Publishing: 145] [Article Influence: 10.1] [Reference Citation Analysis]
48 Li X, Hu J, Zhang R, Sun X, Zhang Q, Guan X, Chen J, Zhu Q, Li S. Urocortin ameliorates diabetic nephropathy in obese db/db mice. Br J Pharmacol 2008;154:1025-34. [PMID: 18587447 DOI: 10.1038/bjp.2008.155] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
49 Chen-Scarabelli C, Scarabelli TM. Turning necrosis into apoptosis: the exacting task that can enhance survival. Am Heart J 2004;148:196-9. [PMID: 15308988 DOI: 10.1016/j.ahj.2004.03.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
50 Fekete EM, Zorrilla EP. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol. 2007;28:1-27. [PMID: 17083971 DOI: 10.1016/j.yfrne.2006.09.002] [Cited by in Crossref: 181] [Cited by in F6Publishing: 181] [Article Influence: 11.3] [Reference Citation Analysis]
51 De Luca A, Squillacioti C, Pero ME, Paino S, Langella E, Mirabella N. Urocortin-like immunoreactivity in the primary lymphoid organs of the duck (Anas platyrhynchos). Eur J Histochem 2009;53:e20. [PMID: 30256876 DOI: 10.4081/ejh.2009.e20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]